BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11599622)

  • 1. Vulvar cancer--what do we know about our patients?
    Shamini N; Tay EH; Ho TH
    Singapore Med J; 2001 Jul; 42(7):292-6. PubMed ID: 11599622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.
    Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB
    Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating vulvar cancer in the new millennium: are patients receiving optimal care?
    Barbera L; Thomas G; Elit L; Covens A; Fyles A; Osborne R; Yun L
    Gynecol Oncol; 2008 Apr; 109(1):71-5. PubMed ID: 18234304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulval cancer, 1992-2002 audit--multidisciplinary care and prognostic factors.
    Mc Millan HM; Martin F; Walsh TA; Boyd WD; Coughlan BM
    Ir Med J; 2006 Sep; 99(8):234-6. PubMed ID: 17120605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer.
    Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O
    Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathological profile of vulva cancer in southern Thailand: analysis of 66 cases.
    Hanprasertpong J; Chichareon S; Wootipoom V; Buhachat R; Tocharoenvanich S; Geater A
    J Med Assoc Thai; 2005 May; 88(5):575-81. PubMed ID: 16149671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
    Landrum LM; Skaggs V; Gould N; Walker JL; McMeekin DS
    Gynecol Oncol; 2008 Mar; 108(3):584-90. PubMed ID: 18155755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical surgery for T1 and T2 squamous cell carcinoma of the vulva through separate incisions.
    Khobjai A; Srisomboon J; Charoenkwan K; Phongnarisorn C; Suprasert P; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S75-81. PubMed ID: 17722321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.
    Landrum LM; Lanneau GS; Skaggs VJ; Gould N; Walker JL; McMeekin DS; Gold MA
    Gynecol Oncol; 2007 Sep; 106(3):521-5. PubMed ID: 17540438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic data on vulvar cancer: comparison of hospital with population-based data.
    van der Velden J; van Lindert AC; Gimbrere CH; Oosting H; Heintz AP
    Gynecol Oncol; 1996 Sep; 62(3):379-83. PubMed ID: 8812536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
    Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
    Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
    Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
    Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of recurrence of vulvar squamous cell carcinoma: analysis of 18 cases].
    Song YN; Yang JX; Shen K; Huang HF; Pan LY
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(19):1347-9. PubMed ID: 18956707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy.
    Kirby TO; Rocconi RP; Numnum TM; Kendrick JE; Wright J; Fowler W; Mutch DG; Bhoola SM; Huh WK; Straughn JM
    Gynecol Oncol; 2005 Aug; 98(2):309-12. PubMed ID: 15975642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases.
    Bellati F; Angioli R; Manci N; Angelo Zullo M; Muzii L; Plotti F; Basile S; Panici PB
    Gynecol Oncol; 2005 Jan; 96(1):227-31. PubMed ID: 15589606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and radiotherapy in vulvar cancer.
    de Hullu JA; van der Zee AG
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):38-58. PubMed ID: 16829120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer.
    Six L; Polterauer S; Grimm C; Seebacher V; Tempfer C; Heinze G; Joura E; Reinthaller A; Hefler LA
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):217-21. PubMed ID: 17459567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.